Estimated impact of long‐acting injectable PrEP in South Africa: a model comparison analysis
Abstract Introduction Long‐acting injectable cabotegravir (CAB‐LA) demonstrated superiority to daily tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) for human immunodeficiency virus (HIV) pre‐exposure prophylaxis (PrEP) in two clinical trials. This analysis projects the impact of expanding PrE...
Saved in:
| Main Authors: | Sarah E. Stansfield, Mia Moore, Lise Jamieson, Gesine Meyer‐Rath, Leigh F. Johnson, David Kaftan, Anna Bershteyn, Jennifer Smith, Valentina Cambiano, Loveleen Bansi‐Matharu, Andrew Phillips, Jesse Heitner, Ruanne V. Barnabas, Brett Hanscom, Deborah J. Donnell, Marie‐Claude Boily, Dobromir Dimitrov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-07-01
|
| Series: | Journal of the International AIDS Society |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jia2.26453 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PrEP preferences and early acceptability of injectable cabotegravir among pregnant and lactating people in Cape Town, South Africa: findings from the PrEPared to Choose study
by: Nafisa Wara, et al.
Published: (2025-07-01) -
Opportunity for cost savings with a novel differentiated model of PrEP delivery: a comparative costing analysis of six-month PrEP supported by interim HIV self-testing and standard of care PrEP dispensing in Kenya
by: Dorothy I. Mangale, et al.
Published: (2025-07-01) -
Analytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectiveness.
by: Dobromir Dimitrov, et al.
Published: (2013-01-01) -
Dosing forgiveness of oral PrEP for cisgender women remains uncertain
by: Mia Moore, et al.
Published: (2025-05-01) -
MANUFACTURING TECHNOLOGIES OF CAB BODIES FOR MULTI-PURPOSE WHEEL MACHINES
by: L. V. Kukharionok
Published: (2014-04-01)